These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
35. Decrease of D2 receptors indicated by 123I-iodobenzamide single-photon emission computed tomography relates to neurological deficit in treated Wilson's disease. Oertel WH; Tatsch K; Schwarz J; Kraft E; Trenkwalder C; Scherer J; Weinzierl M; Vogl T; Kirsch CM Ann Neurol; 1992 Dec; 32(6):743-8. PubMed ID: 1471864 [TBL] [Abstract][Full Text] [Related]
36. [The differential diagnosis of Parkinson diseases--123I-IBZM-SPECT vs. the apomorphine test]. Hierholzer J; Cordes M; Schelosky L; Sander B; Böck JC; David I; Horowski R; Poewe W Rofo; 1993 Jul; 159(1):86-90. PubMed ID: 8334264 [TBL] [Abstract][Full Text] [Related]
37. [Cerebral SPECT with iodine-123 IBZM in patients with extrapyramidal system disorders: the evaluation of its sensitivity in therapy with dopaminergic drugs]. Hierholzer J; Castelli L; Cordes M; Schelosky L; Poewe W; Felix R Radiol Med; 1996 Mar; 91(3):207-10. PubMed ID: 8628932 [TBL] [Abstract][Full Text] [Related]
38. The multiple phenotypes of corticobasal syndrome and corticobasal degeneration: implications for further study. Boeve BF J Mol Neurosci; 2011 Nov; 45(3):350-3. PubMed ID: 21853287 [TBL] [Abstract][Full Text] [Related]
39. Brain perfusion SPECT in patients with corticobasal degeneration: analysis using statistical parametric mapping. Hossain AK; Murata Y; Zhang L; Taura S; Saitoh Y; Mizusawa H; Oda K; Matsushima E; Okubo Y; Shibuya H Mov Disord; 2003 Jun; 18(6):697-703. PubMed ID: 12784276 [TBL] [Abstract][Full Text] [Related]